Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
Fang
Baijun
B
Henan Tumor Hospital, Henan Institute of Hematology, Henan Medical School, Henan University, Zhengzhou, China.
Song
Yongping
Y
Ma
Jie
J
Zhao
Robert C
RC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced / Q000188:drug therapy
D000970:Antineoplastic Agents; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone